JP2004503482A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004503482A5 JP2004503482A5 JP2002510053A JP2002510053A JP2004503482A5 JP 2004503482 A5 JP2004503482 A5 JP 2004503482A5 JP 2002510053 A JP2002510053 A JP 2002510053A JP 2002510053 A JP2002510053 A JP 2002510053A JP 2004503482 A5 JP2004503482 A5 JP 2004503482A5
- Authority
- JP
- Japan
- Prior art keywords
- particles
- respiratory
- particle
- composition
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002245 particle Substances 0.000 claims 65
- 239000000203 mixture Substances 0.000 claims 24
- 230000000241 respiratory effect Effects 0.000 claims 24
- 239000003814 drug Substances 0.000 claims 22
- 229940079593 drug Drugs 0.000 claims 18
- 239000003795 chemical substances by application Substances 0.000 claims 13
- 239000012867 bioactive agent Substances 0.000 claims 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 6
- 239000000032 diagnostic agent Substances 0.000 claims 5
- 229940039227 diagnostic agent Drugs 0.000 claims 5
- 210000002345 respiratory system Anatomy 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 239000000843 powder Substances 0.000 claims 4
- 102000004190 Enzymes Human genes 0.000 claims 3
- 108090000790 Enzymes Proteins 0.000 claims 3
- 102000018997 Growth Hormone Human genes 0.000 claims 3
- 108010051696 Growth Hormone Proteins 0.000 claims 3
- 102000004877 Insulin Human genes 0.000 claims 3
- 108090001061 Insulin Proteins 0.000 claims 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 claims 3
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 claims 3
- 230000004913 activation Effects 0.000 claims 3
- 239000007801 affinity label Substances 0.000 claims 3
- 229940057282 albuterol sulfate Drugs 0.000 claims 3
- BNPSSFBOAGDEEL-UHFFFAOYSA-N albuterol sulfate Chemical compound OS(O)(=O)=O.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 BNPSSFBOAGDEEL-UHFFFAOYSA-N 0.000 claims 3
- 239000000122 growth hormone Substances 0.000 claims 3
- 229940125396 insulin Drugs 0.000 claims 3
- 229960001361 ipratropium bromide Drugs 0.000 claims 3
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 claims 3
- 210000004072 lung Anatomy 0.000 claims 3
- 230000000069 prophylactic effect Effects 0.000 claims 3
- 230000002685 pulmonary effect Effects 0.000 claims 3
- 229960004017 salmeterol Drugs 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 229940112141 dry powder inhaler Drugs 0.000 claims 2
- 229960002714 fluticasone Drugs 0.000 claims 2
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 claims 2
- 230000002209 hydrophobic effect Effects 0.000 claims 2
- 238000001694 spray drying Methods 0.000 claims 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 claims 1
- -1 fructicazone Chemical compound 0.000 claims 1
- 239000006193 liquid solution Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/591,307 US6858199B1 (en) | 2000-06-09 | 2000-06-09 | High efficient delivery of a large therapeutic mass aerosol |
| PCT/US2001/018491 WO2001095874A2 (en) | 2000-06-09 | 2001-06-08 | Highly efficient delivery of a large therapeutic mass aerosol |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008222436A Division JP2009019047A (ja) | 2000-06-09 | 2008-08-29 | 大治療質量エアロゾルの高度に効率的な送達 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004503482A JP2004503482A (ja) | 2004-02-05 |
| JP2004503482A5 true JP2004503482A5 (enExample) | 2005-05-19 |
Family
ID=24365965
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002510053A Pending JP2004503482A (ja) | 2000-06-09 | 2001-06-08 | 大治療質量エアロゾルの高度に効率的な送達 |
| JP2008222436A Pending JP2009019047A (ja) | 2000-06-09 | 2008-08-29 | 大治療質量エアロゾルの高度に効率的な送達 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008222436A Pending JP2009019047A (ja) | 2000-06-09 | 2008-08-29 | 大治療質量エアロゾルの高度に効率的な送達 |
Country Status (20)
| Country | Link |
|---|---|
| US (6) | US6858199B1 (enExample) |
| EP (2) | EP1296663B1 (enExample) |
| JP (2) | JP2004503482A (enExample) |
| KR (1) | KR100697479B1 (enExample) |
| CN (1) | CN100589796C (enExample) |
| AT (1) | ATE357222T1 (enExample) |
| AU (2) | AU7536801A (enExample) |
| CA (1) | CA2412561C (enExample) |
| DE (1) | DE60127407T2 (enExample) |
| DK (1) | DK1296663T3 (enExample) |
| ES (1) | ES2283417T3 (enExample) |
| IL (1) | IL153281A0 (enExample) |
| MX (1) | MXPA02012023A (enExample) |
| NO (1) | NO20025873L (enExample) |
| NZ (1) | NZ523254A (enExample) |
| PL (1) | PL360287A1 (enExample) |
| PT (1) | PT1296663E (enExample) |
| RU (1) | RU2275900C2 (enExample) |
| SI (1) | SI1296663T1 (enExample) |
| WO (1) | WO2001095874A2 (enExample) |
Families Citing this family (109)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020017295A1 (en) * | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US20060171899A1 (en) * | 1998-12-10 | 2006-08-03 | Akwete Adjei | Water-stabilized aerosol formulation system and method of making |
| US6858199B1 (en) * | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| US6749835B1 (en) * | 1999-08-25 | 2004-06-15 | Advanced Inhalation Research, Inc. | Formulation for spray-drying large porous particles |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| US6613308B2 (en) * | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| US6514482B1 (en) | 2000-09-19 | 2003-02-04 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| US20020150626A1 (en) * | 2000-10-16 | 2002-10-17 | Kohane Daniel S. | Lipid-protein-sugar particles for delivery of nucleic acids |
| TWI324518B (en) | 2001-12-19 | 2010-05-11 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
| CA2479212A1 (en) * | 2002-03-15 | 2003-09-25 | Brigham And Women's Hospital, Inc. | Central airway administration for systemic delivery of therapeutics |
| CA2478974C (en) | 2002-03-20 | 2014-12-16 | Advanced Inhalation Research, Inc. | Inhalable sustained therapeutic formulations |
| US7008644B2 (en) * | 2002-03-20 | 2006-03-07 | Advanced Inhalation Research, Inc. | Method and apparatus for producing dry particles |
| JP4681231B2 (ja) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | 吸入装置 |
| SI2630954T1 (sl) * | 2002-03-20 | 2017-02-28 | Civitas Therapeutics, Inc. | Pulmonalno dovajanje za levodopo |
| US6930137B2 (en) * | 2002-05-31 | 2005-08-16 | Fina Technology, Inc. | Method of improving blown film processing performance and physical properties |
| EP1531794B1 (en) * | 2002-06-28 | 2017-05-10 | Civitas Therapeutics, Inc. | Inhalable epinephrine |
| CA2491129A1 (en) * | 2002-07-03 | 2004-01-15 | Brigham And Women's Hospital, Inc. | Central airway administration for systemic delivery of therapeutics |
| US6966990B2 (en) * | 2002-10-11 | 2005-11-22 | Ferro Corporation | Composite particles and method for preparing |
| US20060147389A1 (en) * | 2004-04-14 | 2006-07-06 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
| US20060178394A1 (en) * | 2003-04-14 | 2006-08-10 | Staniforth John N | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
| US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
| DE10317461A1 (de) * | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung |
| GB0313604D0 (en) * | 2003-06-12 | 2003-07-16 | Britannia Pharmaceuticals Ltd | Delivery device for powdered medicament |
| AU2004249166B2 (en) | 2003-06-13 | 2008-10-09 | Alkermes, Inc. | Low dose pharmaceutical powders for inhalation |
| EP1663159A4 (en) * | 2003-09-10 | 2010-06-09 | Map Pharmaceuticals Inc | AEROSOL FORMULATIONS FOR THE DELIVERY OF DIHYDROERGOTAMINE TO THE SYSTEMIC CIRCULATION BY PULMONARY INHALATION |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| AU2005212315A1 (en) * | 2004-02-10 | 2005-08-25 | Advanced Inhalation Research, Inc. | Particles for inhalation rapid release properties |
| BRPI0510119A (pt) * | 2004-04-23 | 2007-09-25 | Cydex Inc | formulação para dpi contendo sulfoaquil éter de ciclodextrina |
| ATE486064T1 (de) | 2004-08-20 | 2010-11-15 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diceto-piperazine salts for drug delivery |
| SE0402345L (sv) * | 2004-09-24 | 2006-03-25 | Mederio Ag | Uppmätt läkemedelsdos |
| GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| US20060134009A1 (en) * | 2004-12-16 | 2006-06-22 | Daniel Deaver | Low dose corticosteroid powders for inhalation |
| WO2006125153A2 (en) * | 2005-05-18 | 2006-11-23 | Pulmatrix Inc. | Formulations for alteration of biophysical properties of mucosal lining |
| AU2006279700A1 (en) * | 2005-08-11 | 2007-02-22 | President And Fellows Of Harvard College | Methods and compositions for dried cellular forms |
| MX373000B (es) | 2005-09-14 | 2020-05-21 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| SI2952197T1 (sl) | 2005-10-26 | 2017-09-29 | Cydex Pharmaceuticals, Inc. | Sestavki sulfoalkil eter ciklodekstrina in metode priprave le-tega |
| US20070123449A1 (en) * | 2005-11-01 | 2007-05-31 | Advanced Inhalation Research, Inc. | High load particles for inhalation having rapid release properties |
| CN104383546B (zh) | 2006-02-22 | 2021-03-02 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
| GB0616299D0 (en) * | 2006-08-16 | 2006-09-27 | Cambridge Consultants | Drug Capsules for dry power inhalers |
| WO2008057248A2 (en) | 2006-10-26 | 2008-05-15 | Next Breath Llc | Phospholipid-based inhalation system |
| US20080260852A1 (en) * | 2007-01-23 | 2008-10-23 | Ferro Pfanstiehl Laboratories, Inc. | Supercritical fluid extraction produced by in-line homogenization |
| US7745566B2 (en) * | 2007-01-23 | 2010-06-29 | Ferro Corporation | Methods for the purification of polymers |
| PL2425820T3 (pl) * | 2007-02-11 | 2015-08-31 | Map Pharmaceuticals Inc | Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych |
| JP2010527914A (ja) * | 2007-04-26 | 2010-08-19 | クォーク ファーマシューティカルズ インコーポレーティッド | 呼吸器系への抑制性核酸分子の治療的送達 |
| EP2219613A1 (en) * | 2007-10-26 | 2010-08-25 | Università degli Studi di Parma | Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation |
| GB0721394D0 (en) * | 2007-10-31 | 2007-12-12 | Vectura Group Plc | Compositions for trating parkinson's disease |
| EP2220115A2 (en) * | 2007-12-13 | 2010-08-25 | Glaxo Group Limited | Polypeptides, antibody variable domains & antagonists |
| NZ586106A (en) * | 2007-12-20 | 2012-09-28 | Astrazeneca Ab | Device, typically for medicament powder, for deaggregating powder by passing air stream along flat region with recess of brick shape where eddy is generated |
| MY155524A (en) | 2008-06-13 | 2015-10-30 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| EP2609954B1 (en) * | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
| WO2010001932A1 (ja) * | 2008-07-01 | 2010-01-07 | 日東電工株式会社 | 表面被覆微粒子の医薬組成物 |
| EP2328556A4 (en) * | 2008-07-30 | 2013-11-20 | Stc Unm | FORMULATIONS WITH LARGE SUPPORT PARTS FOR AEROSOLS FOR THE INHALATION OF DRY POWDER |
| TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| ES2628077T3 (es) | 2009-02-27 | 2017-08-01 | Pari GmbH Spezialisten für effektive Inhalation | Dispositivo de inhalación de aerosol |
| US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| JP5671001B2 (ja) | 2009-03-26 | 2015-02-18 | パルマトリックス，インコーポレイテッド | 肺疾患を治療するための乾燥粉末製剤および方法 |
| GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
| AU2010259943C1 (en) | 2009-06-12 | 2016-03-03 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| US20110171141A1 (en) * | 2009-06-26 | 2011-07-14 | Kellerman Donald J | Administration of dihydroergotamine mesylate particles using a metered dose inhaler |
| JP5784622B2 (ja) | 2009-11-03 | 2015-09-24 | マンカインド コーポレ−ション | 吸入活動をシミュレートするための装置及び方法 |
| EP2380618A1 (en) * | 2010-04-26 | 2011-10-26 | PARI Pharma GmbH | Operating method for an aerosol delivery device and aerosol delivery device |
| RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
| WO2012030664A1 (en) * | 2010-08-30 | 2012-03-08 | Pulmatrix, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
| US8758824B2 (en) | 2010-08-30 | 2014-06-24 | Pulmatrix, Inc. | Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
| PT2621488T (pt) | 2010-09-29 | 2019-02-12 | Pulmatrix Operating Co Inc | Pós secos catiónicos |
| EP4008326A1 (en) * | 2010-09-29 | 2022-06-08 | Pulmatrix Operating Company, Inc. | Monovalent metal cation dry powders for inhalation |
| MX353285B (es) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Paquete de blister para cartuchos farmaceuticos. |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| PT106094A (pt) | 2012-01-13 | 2013-07-15 | Hovione Farmaciencia S A | Administração por inalação de formulações com dose elevada |
| US20150136130A1 (en) | 2012-02-29 | 2015-05-21 | Pulmatrix, Inc. | Inhalable dry powders |
| AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| RU2495682C1 (ru) * | 2012-07-12 | 2013-10-20 | Дарья Сергеевна Петренко | Способ доставки лекарственного средства при лечении или профилактике табакокурения и/или заболеваний органов дыхания |
| EP2705838A1 (en) * | 2012-09-06 | 2014-03-12 | Xspray Microparticles Ab | Tiotropium preparations |
| WO2014066206A1 (en) * | 2012-10-22 | 2014-05-01 | Civitas Therapeutics , Inc. | Reducing inter-patient variability of levodopa plasma concentrations |
| RU2685718C2 (ru) | 2012-10-22 | 2019-04-23 | Сивитас Терапьютикс, Инк. | Лекарственные формы леводопы для быстрого купирования болезни паркинсона |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| US11052202B2 (en) * | 2012-11-07 | 2021-07-06 | Chiesi Farmaceutici S.P.A. | Drug delivery device for the treatment of patients with respiratory diseases |
| BR112015010601B1 (pt) | 2012-11-09 | 2022-07-19 | Civitas Therapeutics, Inc. | Composição farmacêutica e uso da composição |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| WO2014141069A1 (en) * | 2013-03-14 | 2014-09-18 | Novartis Ag | Deamorphization of spray-dried formulations via spray-blending |
| BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
| KR20150135328A (ko) | 2013-04-01 | 2015-12-02 | 풀매트릭스 인코퍼레이티드 | 티오트로피움 건조 분말 |
| CN105473133A (zh) | 2013-04-30 | 2016-04-06 | 欧缇托匹克公司 | 干粉制剂及使用方法 |
| BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
| CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
| EP3107548B8 (en) | 2014-02-20 | 2022-07-20 | Otitopic Inc. | Dry powder formulations for inhalation |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| CN106659685B (zh) | 2014-04-21 | 2021-02-05 | 丝维塔斯治疗公司 | 快速减轻帕金森病中的运动波动 |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| MA40910A (fr) | 2014-11-07 | 2017-09-12 | Civitas Therapeutics Inc | Poudres de rapamycine pour administration pulmonaire |
| JP6758325B2 (ja) | 2015-06-04 | 2020-09-23 | クリティテック・インコーポレイテッド | タキサン粒子およびその使用 |
| EP3316865A4 (en) | 2015-07-02 | 2019-01-23 | Civitas Therapeutics, Inc. | TRIPTAN POWDER FOR PULMONARY ADMINISTRATION |
| WO2017042696A1 (en) * | 2015-09-09 | 2017-03-16 | Novartis Ag | Targeted delivery of spray-dried formulations to the lungs |
| CN114767860A (zh) | 2016-04-04 | 2022-07-22 | 克里蒂泰克公司 | 实体肿瘤治疗方法 |
| EP3452170A4 (en) | 2016-05-05 | 2020-04-01 | Liquidia Technologies, Inc. | TREPROSTINIL IN POWDER FORM FOR TREATING PULMONAL HYPERTENSION |
| JP7680823B2 (ja) * | 2017-03-07 | 2025-05-21 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | 吸入可能なニコチン製剤、およびその作製および使用方法 |
| CA3063420A1 (en) | 2017-06-09 | 2018-12-13 | Crititech, Inc. | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
| AU2018284247B2 (en) * | 2017-06-14 | 2020-04-30 | Crititech Inc. | Methods for treating lung disorders |
| CA3076919A1 (en) | 2017-10-03 | 2019-04-11 | Crititech, Inc. | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer |
| WO2020182603A1 (en) * | 2019-03-08 | 2020-09-17 | Chromaflo Technologies Europe B.V. | Solid colorant dispensing unit and tinting machine comprising the same |
| CN113318097A (zh) * | 2021-04-29 | 2021-08-31 | 珠海瑞思普利医药科技有限公司 | 一种抗特发性肺纤维化的粉雾剂及制备方法 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
| US5260306A (en) | 1981-07-24 | 1993-11-09 | Fisons Plc | Inhalation pharmaceuticals |
| DE3268533D1 (en) * | 1981-07-24 | 1986-02-27 | Fisons Plc | Inhalation drugs, methods for their production and pharmaceutical formulations containing them |
| IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| US5174988A (en) * | 1989-07-27 | 1992-12-29 | Scientific Development & Research, Inc. | Phospholipid delivery system |
| US5304125A (en) | 1990-10-05 | 1994-04-19 | The University Of North Carolina | Apparatus for administering solid particulate aerosols to the lungs |
| US5993805A (en) | 1991-04-10 | 1999-11-30 | Quadrant Healthcare (Uk) Limited | Spray-dried microparticles and their use as therapeutic vehicles |
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| SE9203743D0 (sv) | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
| US5506203C1 (en) | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
| US5830853A (en) | 1994-06-23 | 1998-11-03 | Astra Aktiebolag | Systemic administration of a therapeutic preparation |
| TW402506B (en) | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
| GB9313650D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
| GB9313642D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
| DE69535897D1 (de) * | 1994-03-07 | 2009-01-22 | Nektar Therapeutics | Verfahren und Zusammensetzung für die pulmonale Darreichung von Insulin |
| US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
| GB9413202D0 (en) | 1994-06-30 | 1994-08-24 | Univ Bradford | Method and apparatus for the formation of particles |
| US5641510A (en) | 1994-07-01 | 1997-06-24 | Genentech, Inc. | Method for treating capsules used for drug storage |
| RU2147226C1 (ru) | 1994-09-29 | 2000-04-10 | Квадрант Хэлткэа (Ю Кей) Лимитед | Высушенные распылением микрочастицы как терапевтические носители |
| US6165463A (en) | 1997-10-16 | 2000-12-26 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
| AU706195B2 (en) | 1995-04-14 | 1999-06-10 | Inhale Therapeutic Systems | Powdered pharmaceutical formulations having improved dispersibility |
| US6019968A (en) | 1995-04-14 | 2000-02-01 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
| US6258341B1 (en) | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
| US6254854B1 (en) * | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
| US6503480B1 (en) * | 1997-05-23 | 2003-01-07 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US5874064A (en) * | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US6652837B1 (en) * | 1996-05-24 | 2003-11-25 | Massachusetts Institute Of Technology | Preparation of novel particles for inhalation |
| USRE37053E1 (en) | 1996-05-24 | 2001-02-13 | Massachusetts Institute Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| GB9621825D0 (en) | 1996-10-19 | 1996-12-11 | Andaris Ltd | Microparticles and their use as therapeutic vehicles |
| DE69732306T2 (de) | 1997-01-16 | 2006-01-12 | Massachusetts Institute Of Technology, Cambridge | Zubereitung von partikelhaltigen arzneimitteln zur inhalation |
| ATE248583T1 (de) | 1997-09-29 | 2003-09-15 | Nektar Therapeutics | In dosierinhalatoren verwendbare, stabilisierte zubereitungen |
| US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| US20010053761A1 (en) * | 1998-01-08 | 2001-12-20 | Dimarchi Richard Dennis | Method for administering aspb28-human insulin |
| US6284282B1 (en) * | 1998-04-29 | 2001-09-04 | Genentech, Inc. | Method of spray freeze drying proteins for pharmaceutical administration |
| ES2198922T3 (es) | 1998-06-24 | 2004-02-01 | Advanced Inhalation Research, Inc. | Particulas porosas grandes emitadas por un inhalador. |
| CA2341624C (en) | 1998-08-25 | 2008-12-02 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| GB9827145D0 (en) | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
| US6858199B1 (en) * | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
| US6586008B1 (en) | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| DE60025019T2 (de) * | 1999-10-29 | 2006-08-24 | Nektar Therapeutics, San Carlos | Trockenpulverzusammensetzungen mit verbesserter dispersivität |
| WO2001051030A1 (en) | 2000-01-10 | 2001-07-19 | Dura Pharmaceuticals, Inc. | Pharmaceutical formulation and method for pulmonary and oral delivery |
| US6848197B2 (en) * | 2001-04-18 | 2005-02-01 | Advanced Inhalation Research, Inc. | Control of process humidity to produce large, porous particles |
-
2000
- 2000-06-09 US US09/591,307 patent/US6858199B1/en not_active Expired - Lifetime
-
2001
- 2001-06-08 MX MXPA02012023A patent/MXPA02012023A/es active IP Right Grant
- 2001-06-08 PL PL36028701A patent/PL360287A1/xx not_active Application Discontinuation
- 2001-06-08 AU AU7536801A patent/AU7536801A/xx active Pending
- 2001-06-08 KR KR1020027016748A patent/KR100697479B1/ko not_active Expired - Fee Related
- 2001-06-08 DK DK01942072T patent/DK1296663T3/da active
- 2001-06-08 EP EP01942072A patent/EP1296663B1/en not_active Revoked
- 2001-06-08 ES ES01942072T patent/ES2283417T3/es not_active Expired - Lifetime
- 2001-06-08 EP EP07000049A patent/EP1767196A3/en not_active Withdrawn
- 2001-06-08 AT AT01942072T patent/ATE357222T1/de not_active IP Right Cessation
- 2001-06-08 CN CN01812533A patent/CN100589796C/zh not_active Expired - Fee Related
- 2001-06-08 DE DE60127407T patent/DE60127407T2/de not_active Revoked
- 2001-06-08 NZ NZ523254A patent/NZ523254A/en unknown
- 2001-06-08 RU RU2002134467/15A patent/RU2275900C2/ru not_active IP Right Cessation
- 2001-06-08 AU AU2001275368A patent/AU2001275368B2/en not_active Ceased
- 2001-06-08 JP JP2002510053A patent/JP2004503482A/ja active Pending
- 2001-06-08 WO PCT/US2001/018491 patent/WO2001095874A2/en not_active Ceased
- 2001-06-08 PT PT01942072T patent/PT1296663E/pt unknown
- 2001-06-08 US US09/878,146 patent/US7556798B2/en not_active Expired - Lifetime
- 2001-06-08 IL IL15328101A patent/IL153281A0/xx unknown
- 2001-06-08 CA CA002412561A patent/CA2412561C/en not_active Expired - Fee Related
- 2001-06-08 SI SI200130734T patent/SI1296663T1/sl unknown
-
2002
- 2002-12-06 NO NO20025873A patent/NO20025873L/no not_active Application Discontinuation
-
2003
- 2003-10-08 US US10/681,416 patent/US6921528B2/en not_active Expired - Lifetime
-
2008
- 2008-08-29 JP JP2008222436A patent/JP2009019047A/ja active Pending
- 2008-10-17 US US12/253,449 patent/US20090068274A1/en not_active Abandoned
-
2011
- 2011-12-22 US US13/334,236 patent/US8628754B2/en not_active Expired - Fee Related
-
2013
- 2013-12-10 US US14/101,500 patent/US20140178476A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001275368A1 (en) | Highly efficient delivery of a large therapeutic mass aerosol | |
| WO2001095874A2 (en) | Highly efficient delivery of a large therapeutic mass aerosol | |
| CN100522142C (zh) | 对生产过程中的湿度进行控制以生产较大的多孔微粒 | |
| RU2002134467A (ru) | Способ высокоэффективной доставки аэрозоля с большой терапевтической массой | |
| US6616914B2 (en) | Method for pulmonary and oral delivery of pharmaceuticals | |
| ES2205210T3 (es) | Procedimientos de inhalacion de polvos secos. | |
| JP4378057B2 (ja) | 流動抵抗調節されたエアロゾル化活性薬剤送達 | |
| US11819569B2 (en) | Treating inflammation with inhaled aspirin | |
| JP2003507410A5 (enExample) | ||
| JP2002518432A5 (enExample) | ||
| US12201766B2 (en) | Dry powder nebulizer | |
| CN110603034A (zh) | 一种适于肺、鼻、舌下和/或咽递送的，负载有至少一种生物活性化合物的多孔二氧化硅粒子的制造方法 | |
| WO2009158300A1 (en) | Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof | |
| WO2022116792A1 (zh) | 一种用于治疗肺结核的异烟肼干粉吸入剂 | |
| WO2013104892A1 (en) | Application of high dose compounds via inhalation | |
| CN101926822A (zh) | 一种二氧化硅介孔材料在制备重金属中毒的解毒药物中的应用 | |
| CN111358773B (zh) | 一种帕拉米韦干粉吸入剂及其制备方法 | |
| MXPA06014502A (es) | Reduccion de retencion de polvo en superficies. | |
| JP4266399B2 (ja) | 粉末状吸入用医薬品組成物 | |
| JP2005531604A5 (enExample) | ||
| EP1110547A2 (en) | Helium and neon as means delivering drug in inhaler | |
| US20030026767A1 (en) | Method to aerosolize Interferon-Gamma for lung delivery for local and systemic treatments | |
| HK40020066A (en) | Dry powder formulations and methods of use |